More Socialized Medicine: CASE Opposes Dangerous Anti-Consumer Healthcare Proposal
June 29, 2020 As an advocate for consumers across the country, CASE urges House lawmakers to vote against H.R. 1425,...
CASE Op-Ed – Washington Times: Hospital Pre-payment is the Wrong Response to Beating Covid-19
Gerard Scimeca – Chairman, CASE April 16, 2020 In news that should surprise absolutely nobody, America’s healthcare professionals have...
ER Patients Get Rude Awakening from Health Insurance Policy Denying Coverage
The last thing anyone wants to do is visit the emergency room. But when Americans are facing a crisis, ERs...
CASE Statement on CHIP Reauthorization
Consumer Action for a Strong Economy (CASE) — the nation’s preeminent free-market consumer advocacy organization – today issued the following...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/